Title(s):
NRG-GI004/SWOG-S1610. Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GI005 Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
A221805 Duloxetine To Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II To Phase III Study
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
A021806. A phase III trial of perioperative versus adjuvant chemotherapy for resectable pancreatic cancer
Investigator(s): Esther Rehmus, MD
Contact Information: McDowell Cancer Research at 330.344.6348
Title(s):
NRG-GI008 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Investigator(s): Kathryn Leininger, MD
Contact Information: McDowell Cancer Research 330.344.6348
